Journal of Ophthalmology / 2020 / Article / Tab 3

Research Article

Efficacy and Safety Outcomes of Intravitreal Dexamethasone Implant Therapy for the Treatment of Adult Coats’ Disease

Table 3

Treatments and retinal outcome details of patients with Stage 3A Coats’ disease.

Case no.Baseline BCVA (logMAR)Initial treatmentsAdditional treatmentReason for additional treatmentTime to additional treatmentFollowing time (months)Final BCVA (logMAR)Final retinal outcome

Case 11DEX, VC, and laser160.1Reattachment of ERD, lipid exudative absorbed
Case 21.398DEX, followed by laser after 1 monthAnti-VEGFRetinal haemorrhage, leakage of retinal telangiectasia3 months61.0Reattachment of ERD, lipid exudative absorbed
Case 3FC/30 cmLaser, DEX121.85Macular subretinal scar
Case 4FC/30 cmLaser, DEXAnti-VEGFMacular ERD, neovascularization1 week61.0Persistence ERD
Case 51.301Laser, DEXDEXRecurrent macular ERD10 months181.0Reattachment of ERD, lipid exudative absorbed
Case 60.301Laser, DEXAnti-VEGFMacular ERD1 week60.1Reattachment of ERD, lipid exudative absorbed
Case70.523Laser, IVC80.8Persistence ERD
Case 80.523Laser, IVCTTTTemporal and nasal side capillary telangiectasia8 months80.5Persistence ERD
Case 91.85Laser, IVCPPVExtensive posterior pole ERD, macular hole4 months61.85Persistence ERD
Case 100.5Laser, IVC110.7Reattachment of ERD, lipid exudative reduced

BCVA: best-corrected visual acuity. logMAR: 10 logarithm of minimum angle of resolution letters. CRT: central retinal thickness. IOP: intraocular pressure. DEX: dexamethasone intravitreal implant. IVC: intravitreal injection of conbercept. PPV: pars plana vitrectomy. ERD: exudative retinal detachment. TTT: transpupillary thermotherapy.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.